IL18 and neoplasm: eATP metabolism in the TME is required for tumor-supportive immune environment including increase of immunosuppressive myeloid cells and decrease of intratumor T cell activation, through blocking the tumor-suppressing eATP–P2X7R (an ATP-gated channel)–inflammasome–IL-18 pathway.